EP Patent

EP1785141A1 — Stabilized lanthanum carbonate compositions

Assigned to Shire International Licensing BV · Expires 2007-05-16 · 19y expired

What this patent protects

Stabilized lanthanum carbonate compositions containing a monosaccharide or disaccharide stabilizing agent are disclosed. Subjects having hyperphosphatemia can be treated by administering a pharmaceutical composition containing a therapeutically effective amount of the stabilized …

USPTO Abstract

Stabilized lanthanum carbonate compositions containing a monosaccharide or disaccharide stabilizing agent are disclosed. Subjects having hyperphosphatemia can be treated by administering a pharmaceutical composition containing a therapeutically effective amount of the stabilized lanthanum carbonate formulation.

Drugs covered by this patent

Patent Metadata

Patent number
EP1785141A1
Jurisdiction
EP
Classification
—
Expires
2007-05-16
Drug substance claim
No
Drug product claim
No
Assignee
Shire International Licensing BV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.